LifeVantage Corp (Pre-Reincorporation) Stock Research

Market Summary

USD4.60+0.04

Market Closed

0.88%

LFVN Alerts

2 major insider buys recently.

LFVN Stock Price

LFVN RSI Chart

LFVN Valuation

Market Cap

58.7M

Price/Earnings (Trailing)

-69.77

Price/Sales (Trailing)

0.28

EV/EBITDA

9.85

Price/Free Cashflow

19.42

LFVN Price/Sales (Trailing)

LFVN Profitability

EBT Margin

0.26%

Return on Equity

-2.27%

Return on Assets

-1.07%

Free Cashflow Yield

5.15%

LFVN Fundamentals

LFVN Revenue

Revenue (TTM)

210.1M

Revenue Y/Y

7.47%

Revenue Q/Q

0.15%

LFVN Earnings

Earnings (TTM)

-842.0K

Earnings Y/Y

-10.43%

Earnings Q/Q

196.6%

Price Action

52 Week Range

3.044.92

(Low)(High)

Last 7 days

1.6%

Last 30 days

39.4%

Last 90 days

20.4%

Trailing 12 Months

12.5%

LFVN Financial Health

Current Ratio

1.9

LFVN Investor Care

Shares Dilution (1Y)

1.54%

Diluted EPS (TTM)

-0.06

Peers (Alternatives to LifeVantage Pre-Reincorporation)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	357.9B	81.0B	-8.44%	-2.41%	25.07	4.46	1.70%	-1.88%
EL	68.6B	15.9B	-22.22%	-23.80%	45.46	4.33	-12.42%	-53.65%
CL	63.2B	18.3B	-6.08%	-3.75%	35.42	3.52	4.93%	-21.82%
CHD	22.4B	311.6M	-5.56%	2.20%	54.18	71.76	-94.06%	-49.12%
CLX	19.4B	7.2B	-5.24%	7.30%	262.16	2.71	0.89%	-83.84%
MID-CAP
COTY	9.4B	5.4B	-7.08%	55.79%	48.53	1.75	3.31%	-45.41%
IPAR	4.1B	1.1B	-15.47%	74.73%	29.4	3.58	23.19%	46.99%
SMALL-CAP
NUS	2.0B	2.1B	-13.84%	-26.26%	19.48	0.92	-19.87%	-44.11%
USNA	1.2B	974.1M	-6.04%	-12.98%	18.44	1.24	-15.40%	-39.77%
HLF	1.2B	5.1B	-20.79%	-47.48%	4.6	0.23	-9.16%	-36.58%
NATR	212.2M	420.1M	1.64%	-10.16%	385.75	0.51	-7.10%	-98.18%
LFVN	58.7M	210.1M	39.39%	12.47%	-69.77	0.28	-0.04%	-108.92%
MTEX	23.4M	137.2M	0.77%	-52.70%	-5.22	0.17	-14.12%	-145.62%
GHSI	7.6M	11.9M	6.75%	3380.02%	-0.84	0.64	26.28%	66.80%

Financials for LifeVantage Pre-Reincorporation

* denotes actual numbers (not divided by Thousands)
Income Statement (Last 12 Months)					(In Thousands)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	1.8%	210,120	206,383	204,910	206,360	210,194
Gross Profit	1.7%	168,470	165,694	166,302	168,263	171,647
Operating Expenses	1.8%	165,317	162,315	162,049	160,688	158,986
S&GA Expenses	3.6%	69,629	67,237	65,078	63,425	60,624
EBITDA	-8.8%	4,036	4,424	7,962	15,431	-
EBITDA Margin	-9.4%	0.02*	0.02*	0.04*	0.07*	-
Earnings Before Taxes	-16.1%	448	534	1,111	4,691	12,162
EBT Margin	-52.3%	0.00*	0.01*	0.02*	0.06*	-
Interest Expenses	825.0%	37.00	4.00	10.00	7.00	-
Net Income	-16.5%	-842	-723	414	3,120	9,443
Net Income Margin	-273.4%	0.00*	0.00*	0.02*	0.04*	-
Free Cahsflow	-79.4%	878	4,270	6,429	11,809	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	-1.1%	67.00	68.00	68.00	71.00	72.00
Current Assets	0.0%	44.00	44.00	43.00	47.00	45.00
Cash Equivalents	12.4%	20.00	17.00	18.00	20.00	18.00
Inventory	-9.7%	18.00	20.00	19.00	16.00	16.00
Net PPE	1.5%	9.00	9.00	9.00	10.00	10.00
Liabilities	-6.4%	34.00	36.00	36.00	39.00	38.00
Current Liabilities	-8.3%	21.00	23.00	23.00	26.00	24.00
Shareholder's Equity	4.9%	33.00	32.00	32.00	32.00	34.00
Retained Earnings	0.6%	-99.00	-99.64	-98.20	-98.44	-96.18
Additional Paid-In Capital	0.7%	133	133	132	131	131
Shares Outstanding	0.5%	13.00	13.00	13.00	12.00	13.00

* denotes actual numbers (not divided by Thousands)
Cashflow (Last 12 Months)					(In Thousands)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	90.2%	5,845	3,073	6,149	7,959	13,553
Share Based Compensation	47.7%	2,648	1,793	1,725	1,768	1,283
Cashflow From Investing	-28.5%	-2,820	-2,195	-1,879	-1,530	-1,737
Cashflow From Financing	39.6%	-1,916	-3,172	-5,957	-8,952	-11,746
Dividend Payments	33.7%	1,519	1,136	755	378	0.00
Buy Backs	-81.0%	400	2,100	5,300	8,800	12,292

Risks for LFVN

What is the probability of a big loss on LFVN?

100%

Probability that LifeVantage Pre-Reincorporation stock will be more than 20% underwater in next one year

89.6%

Probability that LifeVantage Pre-Reincorporation stock will be more than 30% underwater in next one year.

60.8%

Probability that LifeVantage Pre-Reincorporation stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does LFVN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if LifeVantage Pre-Reincorporation was unfortunately bought at previous high price.

Drawdowns

Returns for LFVN

Cumulative Returns on LFVN

-11.4%

10-Year Cumulative Returns

-13.3%

7-Year Cumulative Returns

-0.8%

5-Year Cumulative Returns

-33.0%

3-Year Cumulative Returns

What are the long-term rolling returns for LFVN?

FIve years rolling returns for LifeVantage Pre-Reincorporation.

Annualized Returns

Which funds bought or sold LFVN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-16	SUSQUEHANNA INTERNATIONAL GROUP, LLP	added	23.26	17,587	110,382	-%
2023-05-15	CITADEL ADVISORS LLC	reduced	-32.68	-42,043	77,975	-%
2023-05-15	Royal Bank of Canada	reduced	-12.48	-21,000	111,000	-%
2023-05-15	VANGUARD GROUP INC	added	0.04	-59,508	1,664,060	-%
2023-05-15	BRIDGEWAY CAPITAL MANAGEMENT, LLC	reduced	-2.09	-30,755	527,245	0.01%
2023-05-15	GEODE CAPITAL MANAGEMENT, LLC	unchanged	-	-14,757	423,243	-%
2023-05-15	MILLENNIUM MANAGEMENT LLC	reduced	-1.63	-13,000	241,000	-%
2023-05-15	NORTHERN TRUST CORP	reduced	-0.21	-2,675	69,635	-%
2023-05-15	STATE STREET CORP	reduced	-50.00	-177,836	165,826	-%
2023-05-15	MORGAN STANLEY	reduced	-4.07	-10,424	129,947	-%

Latest Funds Activity

Are funds buying LFVN calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own LFVN

No. of Funds

LFVN Alerts

2 major insider buys recently.

LifeVantage Pre-Reincorporation News

Schedule 13G FIlings of LifeVantage Pre-Reincorporation

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
May 15, 2023	radoff bradley louis	5.7%	25,728	SC 13D
Feb 13, 2023	renaissance technologies llc	6.76%	858,718	SC 13G/A
Feb 09, 2023	vanguard group inc	3.69%	463,326	SC 13G/A
Sep 06, 2022	sudbury capital fund, lp	5.1%	643,023	SC 13D
Feb 11, 2022	renaissance technologies llc	7.85%	1,008,818	SC 13G/A
Feb 10, 2022	vanguard index funds	5.38%	712,453	SC 13G/A
Feb 10, 2022	vanguard group inc	5.38%	712,453	SC 13G/A
Jul 12, 2021	blackrock inc.	1.9%	265,364	SC 13G/A
Feb 11, 2021	renaissance technologies llc	8.83%	1,249,805	SC 13G/A
Feb 10, 2021	vanguard group inc	8.20%	1,169,132	SC 13G

LFVN Fair Value

Show Fair-Value

Recent SEC filings of LifeVantage Pre-Reincorporation

View All Filings

Date Filed	Form Type	Document
May 26, 2023	4	Insider Trading
May 15, 2023	SC 13D	13D - Major Acquisition
May 12, 2023	4	Insider Trading
May 11, 2023	4	Insider Trading
May 04, 2023	10-Q	Quarterly Report
May 04, 2023	8-K	Current Report
May 02, 2023	4	Insider Trading
Apr 28, 2023	4	Insider Trading
Apr 17, 2023	8-K	Current Report
Apr 06, 2023	EFFECT	EFFECT

Latest Insider Trading transactions for LFVN

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-25	BEINDORFF MICHAEL A	bought	8,420	4.21	2,000	-
2023-05-24	BEINDORFF MICHAEL A	bought	13,200	4.4	3,000	-
2023-05-12	Mauro Garry Paul	bought	631	4.2074	150	-
2023-05-10	Mauro Garry Paul	bought	693	4.0799	170	-
2023-05-10	Mauro Garry Paul	bought	14,891	4.0799	3,650	-
2023-05-09	Lewis Darwin	bought	3,878	3.8784	1,000	-

About LifeVantage Pre-Reincorporation

Steven R. Fife

www.lifevantage.com

260

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.

LFVN Income Statement

2023-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue, net	$ 53,741	$ 50,004	$ 159,177	$ 155,418
Cost of sales	10,618	9,657	32,318	28,765
Gross profit	43,123	40,347	126,859	126,653
Operating expenses:
Commissions and incentives	23,816	23,206	71,185	72,760
Selling, general and administrative	17,708	15,316	54,018	47,813
Total operating expenses	41,524	38,522	125,203	120,573
Operating income	1,599	1,825	1,656	6,080
Other income (expense):
Interest income (expense), net	59	(5)	91	(10)
Other income (expense), net	7	(69)	(304)	(385)
Total other income (expense)	66	(74)	(213)	(395)
Income before income taxes	1,665	1,751	1,443	5,685
Income tax expense	(643)	(610)	(869)	(1,149)
Net income	$ 1,022	$ 1,141	$ 574	$ 4,536
Net income per share:
Basic (in USD per share)	$ 0.08	$ 0.09	$ 0.05	$ 0.34
Diluted (in USD per share)	$ 0.08	$ 0.09	$ 0.05	$ 0.34
Weighted-average shares outstanding:
Basic (in shares)	12,615	13,195	12,538	13,261
Diluted (in shares)	12,770	13,257	12,555	13,312
Other comprehensive gain (loss), net of tax:
Foreign currency translation adjustment	$ 14	$ (290)	$ 144	$ (604)
Other comprehensive gain (loss), net of tax	14	(290)	144	(604)
Comprehensive income	$ 1,036	$ 851	$ 718	$ 3,932

LFVN Balance Sheet

2023-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Current assets
Cash and cash equivalents	$ 19,529	$ 20,190
Accounts receivable	2,353	3,338
Income tax receivable	662	1,752
Inventory, net	18,452	16,472
Prepaid expenses and other	3,346	5,205
Total current assets	44,342	46,957
Long-term assets
Property and equipment, net	9,454	9,500
Right-of-use assets	9,249	11,040
Intangible assets, net	488	587
Deferred income tax asset	2,242	1,289
Other long-term assets	1,307	1,333
TOTAL ASSETS	67,082	70,706
Current liabilities
Accounts payable	5,823	7,462
Commissions payable	7,071	7,285
Income tax payable	0	453
Lease liabilities	1,774	2,601
Other accrued expenses	6,734	7,927
Total current liabilities	21,402	25,728
Long-term lease liabilities	11,919	13,154
Other long-term liabilities	319	308
Total liabilities	33,640	39,190
Commitments and contingencies - Note 8
Stockholders’ equity
Preferred stock — par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding	0	0
Common stock — par value $0.0001 per share, 40,000 shares authorized and 12,771 and 12,493 issued and outstanding as of March 31, 2023 and June 30, 2022, respectively	1	1
Additional paid-in capital	133,424	131,075
Accumulated deficit	(99,004)	(98,437)
Accumulated other comprehensive loss	(979)	(1,123)
Total stockholders’ equity	33,442	31,516
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 67,082	$ 70,706